Clinical Trial Update: The Immunogenicity and Safety of the Booster Doses of a Live-attenuated Mumps Vaccine in Junior High School Students [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing immunogenicity and safety of booster doses of a live-attenuated mumps vaccine in junior high school students.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mumps

Drugs mentioned

• Live attenuated mumps vaccine (mumps vaccine, live attenuated)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Mumps, Influenza | Phase 4 | Status: UNKNOWN